Some HIV-1 carriers who have received an early antiretroviral treatment during several years are able to control the virus for a long term after treatment interruption. However, the mechanisms ...

In a recent study published in the Advanced Science journal, researchers assessed the effectiveness of synthetic mucin gels in the inhibition of human immunodeficiency virus-1 (HIV-1) and herpes ...

In a recent study posted to Research Square* preprint server, researchers assessed the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and SARS-CoV envelope (E) proteins on ...

The ability to diagnose an acute HIV-1 infection before there are detectable antibodies to HIV 1/2 is critical to making an early diagnosis and getting the individual into treatment. Approximately ...

Gilead Sciences (GILD) announced on Thursday that its Phase 3 ARTISTRY-1 trial, which tested its new single-tablet regimen of ...

The performance characteristics of a sequential rapid HIV-testing algorithm were poorer than anticipated in a Ugandan study, perhaps due to false-positive results from tests with "faint bands." Rapid ...

Table 3. Summary of case series and cohort studies describing response of HIV-1/2 dual-infected patients on ART in the HAART era. Individual case reports excluded, but are discussed in the main text.

NEWTON I. KUMWENDA, TAHA E. TAHA, DONALD R. HOOVER, DIANE MARKAKIS, GEORGE N. LIOMBA, JOHN D. CHIPHANGWI and DAVID D. CELENTANO Background: HIV-1 surveys in defined populations identify underlying ...